Literature DB >> 9921320

Role of cytokines in the formation and downregulation of hepatic circumoval granulomas and hepatic fibrosis in Schistosoma mansoni-infected mice.

A W Cheever1, D Jankovic, G S Yap, M C Kullberg, A Sher, T A Wynn.   

Abstract

Schistosoma mansoni infections are associated with a strong Th2 cytokine response. Treatment of mice with IL-12 or anti-IL-2 or anti-IL-4 before i.v. injection of eggs increased IFN-gamma production and downregulated Th2 responses and pulmonary granuloma size. Conversely, anti-IFN-gamma antibody treatment increased Th2 responses and granuloma size. Similar manipulation produced less dramatic results in infected mice. However, sensitization of mice with eggs + IL-12 before infection augmented the Th1 response and decreased Th2 cytokines, granuloma size and fibrosis. Antisera to IFN-gamma, TNF-alpha or IL-12 during IL-12-egg immunization partly restored granuloma size and fibrosis following infection. Variations in the size of granulomas in acute (8 week) infections may be influenced primarily by the number and state of activation of T cells. In chronic (12-16 week) infections immunologic downmodulation proceeded normally in mice without functional CD8+ cells and in IFN-gamma KO mice but not in B cell KO (microMT) mice or in mice deficient in FcR expression in spite of the fact that these mice downregulated their T cell and cytokine responses. It is evident that the participation of cytokines in granuloma formation and regulation is complicated and that the mechanisms controlling both these phenomena are likely to involve both T cells and antibody/FcR interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9921320     DOI: 10.1590/s0074-02761998000700004

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  14 in total

1.  Schistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patients.

Authors:  Walaa R Allam; Ahmed Barakat; Zainab Zakaria; Gehan Galal; Tamer S Abdel-Ghafar; Mohamed El-Tabbakh; Nabiel Mikhail; Imam Waked; Sayed F Abdelwahab
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

2.  In vivo imaging of tissue eosinophilia and eosinopoietic responses to schistosome worms and eggs.

Authors:  Stephen J Davies; Steven J Smith; K C Lim; Hongbing Zhang; Anthony F Purchio; James H McKerrow; David B West
Journal:  Int J Parasitol       Date:  2005-07       Impact factor: 3.981

3.  Patterns of chemokine expression in models of Schistosoma mansoni inflammation and infection reveal relationships between type 1 and type 2 responses and chemokines in vivo.

Authors:  M K Park; K F Hoffmann; A W Cheever; D Amichay; T A Wynn; J M Farber
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity.

Authors:  Alexandre dos Santos Pyrrho; Juliene Antonio Ramos; Roberto Moura Neto; Célia Santos da Silva; Henrique Leonel Lenzi; Christina Maeda Takiya; Cerli Rocha Gattass
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Schistosoma infection inhibits cellular immune responses to core HCV peptides.

Authors:  A Farid; M Al-Sherbiny; A Osman; N Mohamed; A Saad; M T Shata; D-H Lee; A M Prince; G T Strickland
Journal:  Parasite Immunol       Date:  2005-05       Impact factor: 2.280

6.  Interleukin-12 promotes pathologic liver changes and death in mice coinfected with Schistosoma mansoni and Toxoplasma gondii.

Authors:  M I Araujo; S K Bliss; Y Suzuki; A Alcaraz; E Y Denkers; E J Pearce
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

7.  Dexamethasone treatment improves morphological and hematological parameters in chronic experimental schistosomiasis.

Authors:  Alexandre S Pyrrho; Henrique Leonel Lenzi; Juliene Antonio Ramos; Roberto Moura-Neto; Fabio Christiane O F Cachem; Célia Santos da Silva; Christina Maeda Takiya; Cerli Rocha Gattass
Journal:  Parasitol Res       Date:  2004-03-04       Impact factor: 2.289

8.  IL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease.

Authors:  Keke C Fairfax; Eyal Amiel; Irah L King; Tori C Freitas; Markus Mohrs; Edward J Pearce
Journal:  PLoS Pathog       Date:  2012-01-26       Impact factor: 6.823

9.  Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis.

Authors:  Naglaa M El-Lakkany; Olfat A Hammam; Walaa H El-Maadawy; Afkar A Badawy; Afaf A Ain-Shoka; Fatma A Ebeid
Journal:  Parasit Vectors       Date:  2012-01-11       Impact factor: 3.876

10.  Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil.

Authors:  Deborah Negrão-Corrêa; Juliana F Fittipaldi; José Roberto Lambertucci; Mauro Martins Teixeira; Carlos Maurício de Figueiredo Antunes; Mariângela Carneiro
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.